Skip to main content
Toggle navigation
Search
Home
Full Schedule
All Days
Fri, Sep 25
Sat, Sep 26
Sun, Sep 27
Mon, Sep 28
Tue, Sep 29
Full Schedule
Type here to filter the list
Saturday, September 26, 2026
7:00 AM - 7:00 PM
EDT
ACCP Registration Open
7:00 AM - 7:00 PM
EDT
ACCP Registration Open
8:00 AM - 3:00 PM
EDT
ACCP Board of Regents Meeting (Invitation only)
8:00 AM - 3:00 PM
EDT
ACCP Board of Regents Meeting (Invitation only)
8:00 AM - 5:00 PM
EDT
Clinical Pharmacology Curriculum Review Course
Co-Chair & Faculty:
Craig W. Hendrix, MD (he/him/his)
– Johns Hopkins Univ
Co-Chair & Faculty:
Lionel Lewis, MD (he/him/his)
– The Geisel School of Medicine at Dartmouth
Evidence-based Medicine/Therapeutic Drug Monitoring/Real World Evidence
8:00 AM - 5:00 PM
EDT
Clinical Pharmacology Curriculum Review Course
Co-Chair & Faculty:
Craig W. Hendrix, MD (he/him/his)
– Johns Hopkins Univ
Co-Chair & Faculty:
Lionel Lewis, MD (he/him/his)
– The Geisel School of Medicine at Dartmouth
Evidence-based Medicine/Therapeutic Drug Monitoring/Real World Evidence
8:00 AM - 5:00 PM
EDT
1 - Goals of a Clinical Pharmacology Curriculum Review Course
Faculty:
Craig W. Hendrix, MD (he/him/his)
– Johns Hopkins Univ
Evidence-based Medicine/Therapeutic Drug Monitoring/Real World Evidence
8:00 AM - 5:00 PM
EDT
2 - Hot Topics - MCQ Format
Faculty:
Lionel Lewis, MD (he/him/his)
– The Geisel School of Medicine at Dartmouth
Evidence-based Medicine/Therapeutic Drug Monitoring/Real World Evidence
8:00 AM - 5:00 PM
EDT
3 - Discussion, Questions & Answers, Learner Feedback & Evaluation
Evidence-based Medicine/Therapeutic Drug Monitoring/Real World Evidence
8:00 AM - 5:00 PM
EDT
Pre-meeting Workshop: Cardiac Safety in Drug Development: Navigating Risk from Preclinical to Labeling
Chair & Faculty:
Hee Jae Choi, PharmD
– Boehringer Ingelheim
Faculty:
Borje Darpo, MD, PhD (he/him/his)
– Clario Holdings Inc & Independent
Faculty:
Joanna Parkinson, PhD
– AstraZeneca plc
Faculty:
Ravi Shankar Singh, PhD, FCP
– Pfizer Inc
Faculty:
Elijah J. Weber, PhD (he/him/his)
– AstraZeneca plc
Clinical Trial Design & Statistical Approaches
CE: 6.0
8:00 AM - 5:00 PM
EDT
Pre-meeting Workshop: Cardiac Safety in Drug Development: Navigating Risk from Preclinical to Labeling
Chair & Faculty:
Hee Jae Choi, PharmD
– Boehringer Ingelheim
Faculty:
Borje Darpo, MD, PhD (he/him/his)
– Clario Holdings Inc & Independent
Faculty:
Joanna Parkinson, PhD
– AstraZeneca plc
Faculty:
Ravi Shankar Singh, PhD, FCP
– Pfizer Inc
Faculty:
Elijah J. Weber, PhD (he/him/his)
– AstraZeneca plc
Clinical Trial Design & Statistical Approaches
CE: 6.0
8:00 AM - 5:00 PM
EDT
1 - Welcome & Overview: Objectives, Logistics & What to Expect
Faculty:
Hee Jae Choi, PharmD
– Boehringer Ingelheim
Clinical Trial Design & Statistical Approaches
8:00 AM - 5:00 PM
EDT
2 - Nonclinical & Clinical Assessment for Cardiac Safety: ICH E14/S7B in Practice of Drug Development
Faculty:
Borje Darpo, MD, PhD (he/him/his)
– Clario & Independent
Clinical Trial Design & Statistical Approaches
8:00 AM - 5:00 PM
EDT
3 - Navigating Regulatory Interactions for Cardiac Safety Evaluation in Drug Development
Clinical Trial Design & Statistical Approaches
8:00 AM - 5:00 PM
EDT
4 - Model-informed Cardiac Safety Strategies: QT Assessment & TQT Waiver Case Studies from Industry
Faculty:
Joanna Parkinson, PhD
– AstraZeneca plc
Clinical Trial Design & Statistical Approaches
8:00 AM - 5:00 PM
EDT
5 - Advancing Regulatory-ready Cardiac Safety Strategies: Quantitative Approaches for Early QT Risk Mitigation & Drug Development Acceleration
Faculty:
Ravi Shankar Singh, PhD, FCP
– Pfizer Inc
Clinical Trial Design & Statistical Approaches
8:00 AM - 5:00 PM
EDT
6 - Presentation 6
Faculty:
Elijah J. Weber, PhD (he/him/his)
– AstraZeneca plc
Clinical Trial Design & Statistical Approaches
8:00 AM - 5:00 PM
EDT
7 - Discussion, Questions & Answers, Learner Feedback & Evaluation
Clinical Trial Design & Statistical Approaches
7:00 PM - 10:00 PM
EDT
PharmaFete
7:00 PM - 10:00 PM
EDT
PharmaFete
